Inmune Bio (INMB) Interest Coverage Ratio (2018 - 2026)
Inmune Bio (INMB) posted Interest Coverage Ratio of 22.44 for Q1 2026, down 123.42% sequentially from 10.04 in Q4 2025, and down 2023.26% YoY from 1.17 in Q1 2025.
Inmune Bio (INMB) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Inmune Bio has reported Interest Coverage Ratio for 9 years, with the latest figure at 22.44 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 2023.26% year-over-year to 22.44 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 167.14 (down 3672.52% YoY) and the FY2025 annual result came in at 1.37, up 17.75% from the prior year.
- Interest Coverage Ratio eased to 22.44 in Q1 2026 per INMB's latest filing, from 10.04 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.01 in Q3 2022 and troughed at 161.65 in Q2 2025.
- A 5-year average of 16.42 and a median of 9.2 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio surged 95.59% in 2024, then plunged 17359.65% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 6.58 in 2022, then tumbled by 43.98% to 9.48 in 2023, then gained by 2.94% to 9.2 in 2024, then declined by 9.17% to 10.04 in 2025, then plunged by 123.42% to 22.44 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 22.44, 10.04, and 6.18 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.42 |
| 10 | Inmune Bio | 61.32 Mn | 42.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.91 |
| Mar 31, 2026 | -22.44 |
| Dec 31, 2025 | -10.04 |
| Sep 30, 2025 | -6.18 |
| Jun 30, 2025 | -161.65 |
| Mar 31, 2025 | -1.06 |
| Dec 31, 2024 | -9.20 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.93 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -9.48 |
| Sep 30, 2023 | -1.74 |
| Jun 30, 2023 | -10.16 |
| Mar 31, 2023 | -10.50 |
| Dec 31, 2022 | -6.58 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -13.74 |
| Mar 31, 2022 | -14.89 |
| Dec 31, 2021 | -20.57 |
| Sep 30, 2021 | -0.20 |